As of the 2023 Journal Citation Reports, Cancer Cell International—a peer-reviewed, open-access journal published by BioMed Central (part of Springer Nature)—has the following metrics:Wikipedia
For more detailed information or to explore submission guidelines, you can visit the journal's official homepage: Cancer Cell International.Research.com+5BioMed Central+5BioMed Central+5

- Impact Factor: 5.3
- 5-Year Impact Factor: 5.0
- SCImago Journal Rank (SJR): 1.257
- Source Normalized Impact per Paper (SNIP): 0.920Wikipedia+10Journal Publishing Guide+10Research.com+10Wikipedia
For more detailed information or to explore submission guidelines, you can visit the journal's official homepage: Cancer Cell International.Research.com+5BioMed Central+5BioMed Central+5
Sources
You said:
which, Q1 quartile, vs. Q4 quartile, is more impactful?
ChatGPT said:
In academic publishing, Q1 and Q4 refer to quartile rankings based on a journal’s impact within its subject area.
Would you like help comparing Q1 journals in your field or selecting the right one for submission?
What do the quartiles mean?
- Q1 (Quartile 1): Top 25% of journals in a field → most impactful
- Q2: 25–50%
- Q3: 50–75%
- Q4 (Quartile 4): Bottom 25% → least impactful in that category
So:
- Q1 = More impactful, more selective, and more widely read
- Q4 = Lower impact, often more niche or emerging
Example:
If Cancer Cell International is ranked as Q1 in Oncology, that means it is among the top-performing journals in that category in terms of citations, visibility, and influence.Would you like help comparing Q1 journals in your field or selecting the right one for submission?
You said:
Impact Factor: 5.3? I remeber its history highest was 6.6
ChatGPT said:
You're correct in recalling that Cancer Cell International once achieved a higher Impact Factor. According to the 2021 Journal Citation Reports, the journal reached its peak Impact Factor of 6.429 .Bioxbio+2Wikipedia+2Wikipedia+2
As of the 2023 report, the Impact Factor stands at 5.3 .
Despite this slight decline, Cancer Cell International maintains a strong position in its field, ranking in the Q1 quartile for both Oncology and Genetics .


As of the 2023 report, the Impact Factor stands at 5.3 .
Despite this slight decline, Cancer Cell International maintains a strong position in its field, ranking in the Q1 quartile for both Oncology and Genetics .
Sources
You said:
IF = 10 is equal to Top 5% of journals in a field ?
ChatGPT said:
An Impact Factor (IF) of 10 is certainly high, but whether it places a journal in the top 5% depends on the specific field of research.
Here's why:
- Impact Factor is relative—a journal with IF = 10 might be:
- Top 1% in fields like oncology, cell biology, or immunology, where IFs can exceed 50 (e.g., Nature Reviews Cancer, Cell, CA: A Cancer Journal for Clinicians).
- Top 5% or even Top 1% in biomedical sciences, genomics, or neuroscience.
- Top 0.1% in fields like mathematics, humanities, or nursing, where most journals have IFs between 1 and 4.
- Top 1% in fields like oncology, cell biology, or immunology, where IFs can exceed 50 (e.g., Nature Reviews Cancer, Cell, CA: A Cancer Journal for Clinicians).
To determine if IF = 10 is Top 5%:
You'd look at the Journal Citation Reports (JCR) for your field and find:- The total number of journals
- The cutoff Impact Factor for the top 5%
- ~250 journals listed
- IF > 10 would likely put you in the top 10–15 journals, which is Top 5%
Summary:
- Yes, IF = 10 is often Top 5%—especially in biomedical sciences
- But you must check the specific category ranking (e.g., Oncology, Biochemistry, Neurology) in JCR or SCImago
You said:
cancer , blood cancer
ChatGPT said:
You're correct in noting that an Impact Factor (IF) of 10 is significant in oncology and hematology, but whether it places a journal in the top 5% depends on the specific field and the total number of journals within that category.
Top Oncology Journals by Impact Factor (2023)
According to the Journal Citation Reports (JCR) and other sources:- CA: A Cancer Journal for Clinicians – IF ~503.1
- Nature Reviews Clinical Oncology – IF ~81.1
- Annals of Oncology – IF ~56.7
- Cancer Cell – IF ~48.8
- Journal of Clinical Oncology – IF ~42.1
- Lancet Oncology – IF ~41.6
- Cancer Discovery – IF ~29.7
- Journal of Hematology & Oncology – IF ~29.5
- Molecular Cancer – IF ~27.7
- Nature Cancer – IF ~23.5
- JAMA Oncology – IF ~22.5
- Journal of Thoracic Oncology – IF ~21.0
- Cancer Communications – IF ~20.1
- Neuro-Oncology – IF ~16.4
- Journal of the National Comprehensive Cancer Network – IF ~14.8
- Blood Cancer Journal – IF ~12.9
- Leukemia – IF ~12.8
- Cancer Research – IF ~12.5
- Seminars in Cancer Biology – IF ~12.1
- JACC: CardioOncology – IF ~12.0 OOIR+2Oncodaily+2OOIR+2BioMed Central+5Scimago+5OOIR+5Wikipedia+3OOIR+3Mike M. Dahl+3
???? Top Hematology Journals by Impact Factor (2023)
Based on available data:- Journal of Hematology & Oncology – IF ~29.5
- Blood – IF ~21.0
- Circulation Research – IF ~16.5
- Lancet Haematology – IF ~15.4
- Blood Cancer Journal – IF ~12.9
- Leukemia – IF ~12.8
- American Journal of Hematology – IF ~10.1
- Experimental Hematology & Oncology – IF ~9.4
- Haematologica – IF ~8.2
- HemaSphere – IF ~7.6 Wikipedia+5OOIR+5Impact Factor for Journal+5
Summary
- Impact Factor (IF) of 10 is a strong indicator of a journal's influence in both oncology and hematology.
- In oncology, it places a journal within the top 7–8%.
- In hematology, it places a journal within the top 5–7%.
If you're considering submitting your work, targeting journals with an IF around 10 is a strategic choice for high visibility and impact in these fields.
Sources